Cargando…

Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of Breast

SIMPLE SUMMARY: Tumor-infiltrating lymphocytes (TILs) are prognostic in invasive breast cancer. However, their prognostic significance in ductal carcinoma in situ (DCIS) has been controversial. We used different scoring methods for TILs in multi-national cohorts from Asian and European women. Stroma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Badve, Sunil S., Cho, Sanghee, Lu, Xiaoyu, Cao, Sha, Ghose, Soumya, Thike, Aye Aye, Tan, Puay Hoon, Ocal, Idris Tolgay, Generali, Daniele, Zanconati, Fabrizio, Harris, Adrian L., Ginty, Fiona, Gökmen-Polar, Yesim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406008/ https://www.ncbi.nlm.nih.gov/pubmed/36010908 http://dx.doi.org/10.3390/cancers14163916

Ejemplares similares

Predicting Breast Cancer Events in Ductal Carcinoma In Situ (DCIS) Using Generative Adversarial Network Augmented Deep Learning Model
por: Ghose, Soumya, et al.
Publicado: (2023)

Multi-protein spatial signatures in ductal carcinoma in situ (DCIS) of breast
por: Badve, Sunil S., et al.
Publicado: (2021)

Is conservative management of ductal carcinoma in situ risky?
por: Zheng, Lan, et al.
Publicado: (2022)

Single cell heterogeneity in ductal carcinoma in situ of breast
por: Gerdes, Michael J, et al.
Publicado: (2017)

Upregulation of HSF1 in estrogen receptor positive breast cancer
por: Gökmen-Polar, Yesim, et al.
Publicado: (2016)

More microinvasive foci in larger tumours of breast ductal carcinoma in situ
por: Chen, Xiao-Yang, et al.
Publicado: (2022)

CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer
por: Craven, Kelly E., et al.
Publicado: (2021)

Spatially variant immune infiltration scoring in human cancer tissues
por: Allam, Mayar, et al.
Publicado: (2022)

Clinicopathological characteristics and prognostic analysis of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ (DCIS) and DCIS with microinvasion (DCIS-Mi) of the breast
por: Jia, Huiqing, et al.
Publicado: (2022)

Prognostic Impact of HOTAIR Expression is Restricted to ER-Negative Breast Cancers
por: Gökmen-Polar, Yesim, et al.
Publicado: (2015)

Thymic Carcinomas and Second Malignancies: A Single-Center Review
por: Badve, Sunil S., et al.
Publicado: (2021)

Ductal carcinoma in situ (DCIS)
por: Holland, R
Publicado: (2002)

Three-dimensional imaging and quantitative analysis in CLARITY processed breast cancer tissues
por: Chen, Yi, et al.
Publicado: (2019)

Ductal carcinoma in situ (DCIS): are we overdetecting it?
por: Evans, A
Publicado: (2004)

Ductal carcinoma in situ (DCIS): are we overtreating it?
por: Dixon, JM
Publicado: (2004)

Educational Case: Ductal Carcinoma In Situ (DCIS)
por: Komforti, Miglena K., et al.
Publicado: (2019)

Ductal Carcinoma In Situ (DCIS) and Microinvasive DCIS: Role of Surgery in Early Diagnosis of Breast Cancer
por: Magnoni, Francesca, et al.
Publicado: (2023)

Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer
por: Gökmen-Polar, Yesim, et al.
Publicado: (2018)

Common genetic susceptibility to DCIS and invasive ductal carcinoma
por: Sopik, Victoria, et al.
Publicado: (2016)

ColoType: a forty gene signature for consensus molecular subtyping of colorectal cancer tumors using whole-genome assay or targeted RNA-sequencing
por: Buechler, Steven A., et al.
Publicado: (2020)

Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS)
por: Punglia, Rinaa S, et al.
Publicado: (2018)

Grading Ductal Carcinoma In Situ (DCIS) of the Breast – What’s Wrong with It?
por: Cserni, Gábor, et al.
Publicado: (2019)

A five-gene reverse transcription-PCR assay for pre-operative classification of breast fibroepithelial lesions
por: Tan, Wai Jin, et al.
Publicado: (2016)

GRAM domain-containing protein 1B (GRAMD1B), a novel component of the JAK/STAT signaling pathway, functions in gastric carcinogenesis
por: Khanna, Puja, et al.
Publicado: (2017)

Genomic clustering analysis identifies molecular subtypes of thymic epithelial tumors independent of World Health Organization histologic type
por: Padda, Sukhmani K., et al.
Publicado: (2021)

Vascular density and phenotype around ductal carcinoma in situ (DCIS) of the breast
por: Teo, N B, et al.
Publicado: (2002)

Paget's disease of the male breast with underlying ductal carcinoma in situ (‘DCIS’)
por: Choudhury, Bhuban, et al.
Publicado: (2015)

Cancer-Testis Antigens in Triple-Negative Breast Cancer: Role and Potential Utility in Clinical Practice
por: Lam, Runyi Adeline, et al.
Publicado: (2021)

Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor–Positive, Early Breast Cancer
por: Buechler, Steven A, et al.
Publicado: (2019)

Medullary breast carcinoma: a pathogenic review and immunohistochemical study using tissue microarray
por: Lee, Ming, et al.
Publicado: (2021)

CD1d expression in renal cell carcinoma is associated with higher relapse rates, poorer cancer-specific and overall survival
por: Chong, Tsung Wen, et al.
Publicado: (2015)

Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells
por: Volinia, Stefano, et al.
Publicado: (2018)

Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS)
por: Wärnberg, Fredrik, et al.
Publicado: (2021)

Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma
por: Johnson, C, et al.
Publicado: (2012)

The Emerging Roles of Steroid Hormone Receptors in Ductal Carcinoma in Situ (DCIS) of the Breast
por: Villanueva, Hugo, et al.
Publicado: (2018)

Improving Therapeutic Ratios with the Oncotype DX® Ductal Carcinoma In Situ (DCIS) Score
por: Lalani, Nafisha, et al.
Publicado: (2017)

Expression of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, and Ki-67 in ductal carcinoma in situ (DCIS) and DCIS with microinvasion
por: Wan, Zhi-Bin, et al.
Publicado: (2018)

Prognostic value of tumor-infiltrating lymphocytes in DCIS: a meta-analysis
por: Wu, Shuang-Ling, et al.
Publicado: (2022)

Adipose-enriched peri-tumoral stroma, in contrast to myofibroblast-enriched stroma, prognosticates poorer survival in breast cancers
por: Lau, Hannah Si Hui, et al.
Publicado: (2023)

Molecular Analysis of Thymoma
por: Badve, Sunil, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_37qunr4rklblp0q29oktoa12l0